Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: India Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20083
20092
20103
20112
20121
20132
20151
20161
20171
20191
20201
20212
20233
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting5
Terminated5
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
GlaxoSmithKline3
AstraZeneca2
Eli Lilly and Company2
Pfizer2
Population Health Research Institute2
The George Institute2
Adelaide Institute for Sleep Health1
Alnylam Pharmaceuticals1
Amarin Pharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases32
Myocardial Infarction10
Stroke6
Atherosclerosis5
Diabetes Mellitus, Type 25
Heart Diseases4
Coronary Artery Disease3
Coronary Disease3
Hyperlipidemias3
Renal Insufficiency, Chronic3

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.